WallStreetZenWallStreetZen

NASDAQ: MNKD
Mannkind Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Mannkind earnings were $30.1M for the trailing 12 months ending Mar 31, 2025, with 150% growth year over year. The latest MNKD earnings report on Mar 31, 2025 announced Q1 2025 earnings of $13.2M, up 77.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MNKD reported annual earnings of $27.6M, with -331.1% growth. The next MNKD earnings date is Aug 6, 2025.

MNKD past earnings growth

How has MNKD's earnings growth performed historically?

Company
150%
Industry
24.12%
Market
36.02%
MNKD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MNKD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MNKD's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MNKD earnings history

Current Revenue
$297.6M
Current Earnings
$30.1M
Current Profit Margin
10.1%

MNKD Return on Equity

Current Company
-21%
Current Industry
-60.2%
Current Market
31.3%
MNKD's Return on Equity (-21%)... subscribe to Premium to read more.
High Return on Equity Performance

MNKD undefined

Current Company
7%
Current Industry
-2.5%
MNKD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MNKD announces earnings.

MNKD undefined

Current Company
24.67%
Current Industry
5.8%
MNKD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MNKD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MNKD$82.59M$30.12M+150.00%$0.10
INVA$14.61M-$59.72MN/A-$0.95
PRAX-$211.31M-$212.56MN/A-$10.78
CVAC$256.69M$202.98MN/A$0.91
AUPH$65.88M$39.85MN/A$0.29
View Top Biotech Stocks

MNKD earnings dates

Next earnings date
Aug 6, 2025

Mannkind Earnings Reports & History FAQ

What were Mannkind's earnings last quarter?

On MNKD's earnings call on Invalid Date, Mannkind (NASDAQ: MNKD) reported Q1 2025 earnings per share (EPS) of $0.04, up 0% year over year. Total MNKD earnings for the quarter were $13.16 million. In the same quarter last year, Mannkind's earnings per share (EPS) was $0.04.

If you're new to stock investing, here's how to buy Mannkind stock.

When does Mannkind report earnings?

The next MNKD earnings call is Invalid Date. Add MNKD to your watchlist to be reminded of Mannkind's next earnings date.

Is Mannkind profitable or losing money?

As of the last Mannkind earnings report, Mannkind is currently profitable. Mannkind's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $30.12 million, a 254.85% increase year over year.

What was MNKD's earnings growth in the past year?

As of Mannkind's earnings date in Invalid Date, Mannkind's earnings has grown 150% year over year. This is 125.88 percentage points higher than the US Biotechnology industry earnings growth rate of 24.12%. MNKD earnings in the past year totalled $30.12 million.

What are Mannkind's earnings expectations?

The current EPS estimate for Mannkind's earnings report in Invalid Date is $0.05.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.